BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24517162)

  • 1. Statin use and breast cancer: do we need more evidence and what should this be?
    Bonovas S; Lytras T; Sitaras NM
    Expert Opin Drug Saf; 2014 Mar; 13(3):271-5. PubMed ID: 24517162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based use of statins for primary prevention of cardiovascular disease.
    Minder CM; Blaha MJ; Horne A; Michos ED; Kaul S; Blumenthal RS
    Am J Med; 2012 May; 125(5):440-6. PubMed ID: 22387091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One statin, two statins, three statins, more: similarities and differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Turkoski BB
    Orthop Nurs; 2011; 30(1):62-5; quiz 66-7. PubMed ID: 21278557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?
    Bonovas S
    Drugs; 2014 Oct; 74(16):1841-1848. PubMed ID: 25288321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
    Boudreau DM; Gardner JS; Malone KE; Heckbert SR; Blough DK; Daling JR
    Cancer; 2004 Jun; 100(11):2308-16. PubMed ID: 15160333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies.
    Bonovas S; Filioussi K; Sitaras NM
    Am J Gastroenterol; 2008 Oct; 103(10):2646-51. PubMed ID: 18684187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy.
    Chao C; Williams SG; Xu L; Chen J; Wallner LP; Porter KR; Jacobsen SJ
    Cancer Lett; 2013 Jul; 335(1):214-8. PubMed ID: 23419526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current therapy of hypercholesterolemia. How much statin does your patient need?].
    Schuff-Werner P; Kohlschein P
    MMW Fortschr Med; 2002 Aug; 144(31-32):24-6. PubMed ID: 12422725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and breast cancer: a smoking gun or guilt by association?
    Ahmed MH; Osman MM; Alokail MS
    Expert Opin Drug Saf; 2006 Sep; 5(5):599-601. PubMed ID: 16907648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.
    Chae YK; Valsecchi ME; Kim J; Bianchi AL; Khemasuwan D; Desai A; Tester W
    Cancer Invest; 2011 Nov; 29(9):585-93. PubMed ID: 21936625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and cancer development.
    Duncan RE; El-Sohemy A; Archer MC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1897-8. PubMed ID: 16103434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of the non-statin hypolipidemic agents.
    Rozman D; Monostory K
    Pharmacol Ther; 2010 Jul; 127(1):19-40. PubMed ID: 20420853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
    Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
    BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review.
    Pfefferkorn JA
    Expert Opin Ther Pat; 2011 Feb; 21(2):187-203. PubMed ID: 21214503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and risk of breast cancer: a meta-analysis of observational studies.
    Undela K; Srikanth V; Bansal D
    Breast Cancer Res Treat; 2012 Aug; 135(1):261-9. PubMed ID: 22806241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of statins in children.
    Lamaida N; Capuano E; Pinto L; Capuano E; Capuano R; Capuano V
    Acta Paediatr; 2013 Sep; 102(9):857-62. PubMed ID: 23631461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and prostate cancer: molecular and clinical aspects.
    Papadopoulos G; Delakas D; Nakopoulou L; Kassimatis T
    Eur J Cancer; 2011 Apr; 47(6):819-30. PubMed ID: 21354784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-adherence to statin therapy: a major challenge for preventive cardiology.
    Bates TR; Connaughton VM; Watts GF
    Expert Opin Pharmacother; 2009 Dec; 10(18):2973-85. PubMed ID: 19954271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.